Related Experiment Video
Updated: Jan 13, 2026
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Benefit of Influenza Vaccination in Patients with Cardiovascular Disease
Anshari Saifuddin Hasibuan1, Alvina Widhani2, Sukamto Koesnoe3
11. Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. 2. Department of Internal Medicine, Universitas Indonesia Hospital, Depok, Jawa Barat, Indonesia. 3. Adult Immunization Task Force, Indonesian Society of Internal Medicine, Indonesia.. sorihsb@gmail.com.
Insights
Influenza poses significant risks, especially for individuals with cardiovascular disease. Influenza vaccination is a proven, safe method to prevent infection and reduce major cardiovascular events in these vulnerable populations.
Area of Science:
- Public Health
- Cardiology
- Infectious Diseases
Background:
- Influenza is a major global health concern, with elevated risks for individuals with comorbidities like cardiovascular disease.
- Cardiovascular disease is a leading cause of mortality worldwide and in Indonesia.
- Seasonal influenza outbreaks are linked to increased cardiovascular events.
Purpose of the Study:
- To review the impact of influenza on patients with cardiovascular disease.
- To highlight the benefits of influenza vaccination in this high-risk group.
Main Methods:
- This is a review article.
- It synthesizes existing literature on influenza, cardiovascular disease, and vaccination.
Main Results:
- Influenza vaccination is effective in preventing influenza infection.
- Vaccination significantly reduces the risk of major cardiovascular events in individuals with cardiovascular disease.
- Influenza vaccines are safe and well-tolerated in adults and the elderly.
Conclusions:
- Influenza vaccination is a critical preventive measure for individuals with cardiovascular disease.
- Vaccination mitigates both influenza complications and cardiovascular event risks.
- Promoting influenza vaccination is essential for public health, particularly for vulnerable populations.
Abstract:
Influenza remains a significant global health problem. The risks of complication and death from influenza are greater in comorbid groups, such as those suffering cardiovascular diseases. The true economic and social costs of influenza are far greater in these groups compared to healthy ones as these groups are vulnerable to complications and even death. Cardiovascular disease is the leading cause of death, both globally and in Indonesia. The relationship between cardiovascular events and seasonal influenza has been established. Influenza vaccination is one of the prevention methods that has proven effective in preventing influenza infection and reducing the risk of major cardiovascular events. In addition to being effective, influenza vaccination is also safe and well-tolerated by adults and the elderly. This review outlines the impacts of influenza and the benefits of influenza vaccine in groups with cardiovascular disease.
More Related Videos
Related Concept Videos
01:26Angina IV: Management
01:26Coronary Artery Disease IV: Preventive Measures
01:14Myocarditis III: Medical Management
01:51Vaccinations
01:21Rheumatic Heart Disease III: Medical Management
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...